What does CUSIP 83548R204 represent in this 13F holders report?

CUSIP 83548R204 is the security identifier for SONN - Sonnet BioTherapeutics Holdings, Inc. - COM NEW used to aggregate holder disclosures.

How many institutions held SONN - Sonnet BioTherapeutics Holdings, Inc. - COM NEW in Q4 2023?

No institutional holders were reported for SONN - Sonnet BioTherapeutics Holdings, Inc. - COM NEW in Q4 2023; review adjacent reporting periods for trend context.

Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN)

CUSIP: 83548R204

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / COM NEW
Shares outstanding: 6,190,476
Total 13F shares: 0
Share change: -142
Total reported value: $0
Number of holders: 0
Value change: -$28
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 83548R204?
CUSIP 83548R204 identifies SONN - Sonnet BioTherapeutics Holdings, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2023

Recent filing periods for CUSIP 83548R204:

Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022

Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN)

Q4 2023 13F Holders as of 31 Dec 2023

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of SONN - Sonnet BioTherapeutics Holdings, Inc. - COM NEW as of Q4 2023.